|
|
|
![Sirtex Logo]()
|
|
|
|
![Driven by innovation. inspored by patients.]()
|
|
|
|
Meet SIROS™ at ECIO!
The NEW innovative Delivery System for SIR-Spheres®
|
|
|
|
![]()
|
|
|
|
![]()
|
|
|
|
|
|
|
|
|
|
|
Set your Plans for ECIO 2024 with our Educational Sessions |
|
|
|
|
|
|
Sunday, April 28th |
09:00–17:00
Room Cabrera 4–5 |
Learning Center
Put your hands on SIROS™, the NEW innovative Y-90 Delivery System |
![]() |
|
|
|
|
|
Monday, April 29th |
09:00–13:00
Room Cabrera 4–5 |
Learning Center
Put your hands on SIROS™, the NEW innovative Y-90 Delivery System |
![]() |
14:00–15:00
Room Cabrera 4–5 |
Learning Center
EmboCept® S DSM 50 μm for TACE
Meet the Experts |
![]() |
15:00–17:00
Room Hands-on
SED/MSK/RE |
Hands-On Device Training*
Radioembolization: Dosimetry and administration systems |
![]() |
|
|
|
|
|
Tuesday, April 30th |
08:30–10:30
Room Hands-on SED/MSK/RE |
Hands-On Device Training*
Radioembolization: Dosimetry and administration systems |
![]() |
|
|
|
|
|
*Seats are limited. First come, first served. |
|
|
|
|
|
|
Connect with us and sign up for the latest news on Sirtex |
|
|
|
|
|
![Subscribe Now]()
|
|
|
|
|
|
|
Received this email as a forward? Opt in and we’ll keep you posted about new products and services, research initiatives, and other news of interest to the interventional radiology community. |
|
|
|
|
|
|
|
|
SIR-Spheres Y-90 resin micropsheres
Indications For Use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) or unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. Consult the Instructions for Use (www.Sirtex.com) for a complete listing of indications, contraindications, side effects, warnings, and precautions.
|
|
|
|
![]()
|
Manufacturer
Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410
Europe, Middle East & Africa Sirtex Medical Europe GmbH Joseph-Schumpeter-Allee 33 53227 Bonn Germany Tel: +49 228 1840 730
EmboCept® S DSM 50 μm
Intended Use / Indication For Use: EmboCept S DSM 50 μm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation. Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.
|
|
|
|
![]()
|
Manufacturer
Magle Chemoswed AB, Agneslundsvägen 27, SE-212 15 Malmö, Sweden Phone: +46 (0)40 38 33 00, www.maglechemoswed.com
Distributed by Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards, NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410 EmboCept is a registered trademark of Magle PharmaCept GmbH.
SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. ©2024 Sirtex Medical Europe GmbH APM-EMEA-027-03-24
|
|
|
|
|
